This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Magkos, F. et al. Nat. Metab. 6, 1856–1865 (2024).
Johnson, R. J. et al. Philos. Trans. R. Soc. Lond. B Biol. Sci. 378, 20220230 (2023).
Shapiro, A. et al. Am. J. Physiol. Regul. Integr. Comp. Physiol. 295, R1370–R1375 (2008).
Rorabaugh, J. M., Stratford, J. M. & Zahniser, N. R. PLoS ONE 9, e95019 (2014).
Cox, C. L. et al. Eur. J. Clin. Nutr. 66, 201–208 (2012).
Andres-Hernando, A. et al. Cell Metab. 32, 117–127.e3 (2020).
Softic, S. et al. J. Clin. Invest. 127, 4059–4074 (2017).
Lanaspa, M. A. et al. Nat. Commun. 4, 2434 (2013).
Johnson, R. J., Sánchez-Lozada, L. G. & Lanaspa, M. A. Obesity 32, 12–22 (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
R.J.J. has equity with Colorado Research Partners LLC, which is developing inhibitors of fructose metabolism. T.N. declares no competing interests.
Rights and permissions
About this article
Cite this article
Nakagawa, T., Johnson, R.J. Do not overlook the role of fructose in obesity. Nat Metab (2025). https://doi.org/10.1038/s42255-024-01198-2
Published:
DOI: https://doi.org/10.1038/s42255-024-01198-2